Rhonda M. Chicko

Chief Financial Officer at Caraway Therapeutics

Rhonda M. Chicko is an accomplished financial executive with over 25 years of experience in enhancing performance and developing systems, processes, and procedures to streamline operations for early-stage and high growth companies within the biotechnology and financial services sectors. Most recently, she was Chief Financial Officer at Scholar Rock where sheplayed a key role in Scholar Rock’s initial public offering, subsequent financing, and led the buildout of the financial and operational infrastructure. Prior to joining Scholar Rock she was Vice President, Finance at Editas Medicine, Inc. where she helped build the finance organization. Prior to joining Editas, Ms. Chicko spent 10 years at Ironwood Pharmaceuticals, Inc. in financial roles of increasing responsibility, culminating as Senior Director, Finance and Tax. Earlier in her career, Ms. Chicko held a range of positions at investment management and accounting firms, including Wellington Management Company, LLP and PricewaterhouseCoopers, LLP.

Location

Cambridge, United States

Links


Org chart

No direct reports

Teams


Offices


Caraway Therapeutics

1 followers

Caraway’s therapeutic approach leverages genetic data and unique biological understanding to develop proprietary small molecules that activate cellular clearance and recycling processes – accelerating clearance of accumulated toxic materials and defective cellular components.


Industries

Employees

11-50

Links